參考文獻 |
1. Saman W. Global epidemiology of oral and oropharyngeal cancer. Oral Oncology. 2009;45:309-16.
2. Chen Y-J, Chang JT-C, Liao C-T, Wang H-M, Yen T-C, Chiu C-C, et al. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Science. 2008;99:1507-14.
3. Ho P-S, Ko Y-C, Yang Y-HC, Shieh T-Y, Tsai C-C. The incidence of oropharyngeal cancer in Taiwan: an endemic betel quid chewing area. Journal of Oral Pathology & Medicine. 2002;31:213-9.
4. Punglia RS, Morrow M, Winer EP, Harris JR. Local Therapy and Survival in Breast Cancer. New England Journal of Medicine. 2007;356:2399-405.
5. Lin C-H, Liau J-Y, Lu Y-S, Huang C-S, Lee W-C, Kuo K-T, et al. Molecular Subtypes of Breast Cancer Emerging in Young Women in Taiwan: Evidence for More Than Just Westernization as a Reason for the Disease in Asia. Cancer Epidemiology Biomarkers & Prevention. 2009;18:1807-14.
6. Shen Y-C, Chang C-J, Hsu C, Cheng C-C, Chiu C-F, Cheng A-L. Significant Difference in the Trends of Female Breast Cancer Incidence Between Taiwanese and Caucasian Americans: Implications from Age-Period-Cohort Analysis. Cancer Epidemiology Biomarkers & Prevention. 2005;14:1986-90.
7. Lee K-D, Chen S-C, Chan CH, Lu C-H, Chen C-C, Lin J-T, et al. Increased Risk for Second Primary Malignancies in Women with Breast Cancer Diagnosed at Young Age: A Population-Based Study in Taiwan. Cancer Epidemiology Biomarkers & Prevention. 2008;17:2647-55.
8. Ferlito A, Rinaldo A, Devaney KO, MacLennan K, Myers JN, Petruzzelli GJ, et al. Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodes. Oral Oncology. 2002;38:747-51.
9. Mamelle G, Pampurik J, Luboinski B, Lancar R, Lusinchi A, Bosq J. Lymph node prognostic factors in head and neck squamous cell carcinomas. The American Journal of Surgery. 1994;168:494-8.
10. Liao C-T, Hsueh C, Lee L-Y, Lin C-Y, Fan K-H, Wang H-M, et al. Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy. Oral Oncology. 2012;48:329-36.
11. Kurahara S-i, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A, et al. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: Correlations with tumor invasion and metastasis. Head & Neck. 1999;21:627-38.
12. American Cancer Society. Cancer statistics 1998. CA Cancer J Clin. 1998;48:1 - 63.
13. Taneja P, Maglic D, Kai F, Zhu S, Kendig RD, Fry EA, et al. Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance. Clinical Medicine Insights: Oncology. 2010;4:15-34.
14. Boyd D. Invasion and metastasis. Cancer Metastasis Rev. 1996;15:77 - 89.
15. Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009;11:228-34.
16. Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15:509-24.
17. Bartel DP. MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell. 2004;116:281-97.
18. Zeng Y, Cullen BR. Structural requirements for pre-microRNA binding and nuclear export by Exportin 5. Nucleic Acids Research. 2004;32:4776-85.
19. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes & Development. 2006;20:515-24.
20. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs Exhibit Strand Bias. Cell. 2003;115:209-16.
21. Li S-C, Chan W-C, Ho M-R, Tsai K-W, Hu L-Y, Lai C-H, et al. Discovery and characterization of medaka miRNA genes by next generation sequencing platform. BMC Genomics. 2010;11:S8.
22. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Research. 2006;34:D140-D4.
23. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. MicroRNAs [mdash] the micro steering wheel of tumour metastases. Nat Rev Cancer. 2009;9:293-302.
24. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834-8.
25. Jiang L, Liu X, Kolokythas A, Yu J, Wang A, Heidbreder CE, et al. Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. International Journal of Cancer. 2010;127:505-12.
26. Pérez-Sayáns M, Pilar G-D, Barros-Angueira F, Suárez-Peñaranda JM, Fernández AC, Gándara-Rey JM, et al. Current trends in miRNAs and their relationship with oral squamous cell carcinoma. Journal of Oral Pathology & Medicine. 2012;41:433-43.
27. Negrini M, Calin G. Breast cancer metastasis: a microRNA story. Breast Cancer Research. 2008;10:303.
28. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008;451:147-52.
29. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, et al. A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cells. EMBO reports. 2008;9:582-9.
30. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo Y-Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 0000;18:350-9.
31. Turnover of Focal Adhesions and Cancer Cell Migration. International Journal of Cell Biology. 2012;2012.
32. Hoefen RJ, Berk BC. The multifunctional GIT family of proteins. Journal of Cell Science. 2006;119:1469-75.
33. Hsu R-M, Tsai M-H, Hsieh Y-J, Lyu P-C, Yu J-S. Identification of MYO18A as a Novel Interacting Partner of the PAK2/βPIX/GIT1 Complex and Its Potential Function in Modulating Epithelial Cell Migration. Molecular Biology of the Cell. 2010;21:287-301.
34. Manabe R-i, Kovalenko M, Webb DJ, Horwitz AR. GIT1 functions in a motile, multi-molecular signaling complex that regulates protrusive activity and cell migration. Journal of Cell Science. 2002;115:1497-510.
35. Hajdo-Milasinovic A, van der Kammen RA, Moneva Z, Collard JG. Rac3 inhibits adhesion and differentiation of neuronal cells by modifying GIT1 downstream signaling. Journal of Cell Science. 2009;122:2127-36.
36. Schmalzigaug R, Garron M-L, Roseman JT, Xing Y, Davidson CE, Arold ST, et al. GIT1 utilizes a focal adhesion targeting-homology domain to bind paxillin. Cellular Signalling. 2007;19:1733-44.
37. Zhao Z-s, Manser E, Loo T-H, Lim L. Coupling of PAK-Interacting Exchange Factor PIX to GIT1 Promotes Focal Complex Disassembly. Molecular and Cellular Biology. 2000;20:6354-63.
38. Zhao J, Guan J-L. Signal transduction by focal adhesion kinase in cancer. Cancer and Metastasis Reviews. 2009;28:35-49.
39. Brunton VG, Frame MC. Src and focal adhesion kinase as therapeutic targets in cancer. Current Opinion in Pharmacology. 2008;8:427-32.
40. Subauste MC, Pertz O, Adamson ED, Turner CE, Junger S, Hahn KM. Vinculin modulation of paxillin–FAK interactions regulates ERK to control survival and motility. The Journal of Cell Biology. 2004;165:371-81.
41. Parsons JT. Focal adhesion kinase: the first ten years. Journal of Cell Science. 2003;116:1409-16.
42. Schlaepfer DD, Mitra SK, Ilic D. Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2004;1692:77-102.
43. Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol. 2005;6:56-68.
44. Nicholson RI, Gee JMW, Harper ME. EGFR and cancer prognosis. European Journal of Cancer. 2001;37, Supplement 4:9-15.
45. Ciardiello F, Tortora G. A Novel Approach in the Treatment of Cancer: Targeting the Epidermal Growth Factor Receptor. Clinical Cancer Research. 2001;7:2958-70.
46. Tsai P-C, Hsieh C-Y, Chiu C-C, Wang C-K, Chang L-S, Lin S-R. Cardiotoxin III suppresses MDA-MB-231 cell metastasis through the inhibition of EGF/EGFR-mediated signaling pathway. Toxicon.
47. Yin G, Haendeler J, Yan C, Berk BC. GIT1 Functions as a Scaffold for MEK1-Extracellular Signal-Regulated Kinase 1 and 2 Activation by Angiotensin II and Epidermal Growth Factor. Molecular and Cellular Biology. 2004;24:875-85.
48. Brockschmidt A, Trost D, Peterziel H, Zimmermann K, Ehrler M, Grassmann H, et al. KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas. Brain. 2012;135:1027-41.
49. Chekulaeva M, Mathys H, Zipprich JT, Attig J, Colic M, Parker R, et al. miRNA repression involves GW182-mediated recruitment of CCR4–NOT through conserved W-containing motifs. Nat Struct Mol Biol. 2011;18:1218-26.
50. Peng C-H, Liao C-T, Peng S-C, Chen Y-J, Cheng A-J, Juang J-L, et al. A Novel Molecular Signature Identified by Systems Genetics Approach Predicts Prognosis in Oral Squamous Cell Carcinoma. PLoS ONE. 2011;6:e23452.
51. Lu Y-C, Chen Y-J, Wang H-M, Tsai C-Y, Chen W-H, Huang Y-C, et al. Oncogenic Function and Early Detection Potential of miRNA-10b in Oral Cancer as Identified by microRNA Profiling. Cancer Prevention Research. 2012;5:665-74.
52. Gong BD, Xie Q, Wang L, Xiang XG, Lin LY, Zhao GD, et al. [Real-time quantification of microRNAs in Huh7 cells by stem-loop reverse transcriptase polymerase chain reaction]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 2009;17:603-6.
53. Rong-Mei Wu1 MW, Anthony Thrush2, Eric F. Walton1, and Erika Varkonyi-Gasic1*. Real-Time PCR Quantification of Plant miRNAs Using Universal ProbeLibrary Technology. Biochemica. 2007:12-5.
54. Yeh Y-M, Chuang C-M, Chao K-C, Wang L-H. MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α. International Journal of Cancer. 2013:n/a-n/a.
55. Silahtaroglu AN, Nolting D, Dyrskjot L, Berezikov E, Moller M, Tommerup N, et al. Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification. Nat Protocols. 2007;2:2520-8.
56. Weigelt B, Peterse JL, van′t Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005;5:591-602.
57. Yamamoto E, Miyakawa A, Kohama G-I. Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. Head & Neck Surgery. 1984;6:938-47.
58. Cunningham MJ, Johnson JT, Myers EN, Schramm Jr VL, Thearle PB. Cervical lymph node metastasis after local excision of early squamous cell carcinoma of the oral cavity. The American Journal of Surgery. 1986;152:361-6.
59. Sakamoto S, McCann RO, Dhir R, Kyprianou N. Talin1 Promotes Tumor Invasion and Metastasis via Focal Adhesion Signaling and Anoikis Resistance. Cancer Research. 2010;70:1885-95.
60. Ren Y, Yu L, Fan J, Rui Z, Hua Z, Zhang Z, et al. Phosphorylation of GIT1 tyrosine 321 is required for association with FAK at focal adhesions and for PDGF-activated migration of osteoblasts. Molecular and Cellular Biochemistry. 2012:1-10.
61. Zhang ZM, Simmerman JA, Guibao CD, Zheng JJ. GIT1 Paxillin-binding Domain Is a Four-helix Bundle, and It Binds to Both Paxillin LD2 and LD4 Motifs. Journal of Biological Chemistry. 2008;283:18685-93.
62. Mendes O, Kim H-T, Lungu G, Stoica G. MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2. Clin Exp Metastasis. 2007;24:341-51.
63. Liu Z, Li L, Yang Z, Luo W, Li X, Yang H, et al. Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma. BMC Cancer. 2010;10:270.
64. Luo Y, Liang F, Zhang Z-Y. PRL1 Promotes Cell Migration and Invasion by Increasing MMP2 and MMP9 Expression through Src and ERK1/2 Pathways†. Biochemistry. 2009;48:1838-46.
65. Shim Y-J, Kang B-H, Jeon H-S, Park I-S, Lee K-U, Lee I-K, et al. Clusterin induces matrix metalloproteinase-9 expression via ERK1/2 and PI3K/Akt/NF-κB pathways in monocytes/macrophages. Journal of Leukocyte Biology. 2011;90:761-9.
66. Liao C-T, Huang S-F, Chen IH, Chang J-C, Wang H-M, Ng S-H, et al. Risk Stratification of Patients with Oral Cavity Squamous Cell Carcinoma and Contralateral Neck Recurrence Following Radical Surgery. Ann Surg Oncol. 2009;16:159-70.
67. Capote A, Escorial V, Muñoz-Guerra MF, Rodríguez-Campo FJ, Gamallo C, Naval L. Elective neck dissection in early-stage oral squamous cell carcinoma—does it influence recurrence and survival? Head & Neck. 2007;29:3-11.
68. Greenberg JS, El Naggar AK, Mo V, Roberts D, Myers JN. Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Cancer. 2003;98:508-15.
69. Capote-Moreno A, Naval L, Muñoz-Guerra MF, Sastre J, Rodríguez-Campo FJ. Prognostic Factors Influencing Contralateral Neck Lymph Node Metastases in Oral and Oropharyngeal Carcinoma. Journal of Oral and Maxillofacial Surgery. 2010;68:268-75.
70. Yan W, Zhang W, Sun L, Liu Y, You G, Wang Y, et al. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme. Brain Research. 2011;1411:108-15.
71. Rutnam ZJ, Yang BB. The non-coding 3′ UTR of CD44 induces metastasis by regulating extracellular matrix functions. Journal of Cell Science. 2012;125:2075-85.
72. Wang J, Taba Y, Pang J, Yin G, Yan C, Berk BC. GIT1 Mediates VEGF-Induced Podosome Formation in Endothelial Cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:202-8.
73. Yin G, Zheng Q, Yan C, Berk BC. GIT1 Is a Scaffold for ERK1/2 Activation in Focal Adhesions. Journal of Biological Chemistry. 2005;280:27705-12.
74. Zhang N, Cai W, Yin G, Nagel DJ, Berk BC. GIT1 is a novel MEK1-ERK1/2 scaffold that localizes to focal adhesions. Cell biology international. 2010;34:41-7.
75. Kornberg LJ. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Head & Neck. 1998;20:745-52.
76. Turner CE. Paxillin and focal adhesion signalling. Nat Cell Biol. 2000;2:E231-E6.
77. Hagel M, George EL, Kim A, Tamimi R, Opitz SL, Turner CE, et al. The Adaptor Protein Paxillin Is Essential for Normal Development in the Mouse and Is a Critical Transducer of Fibronectin Signaling. Molecular and Cellular Biology. 2002;22:901-15.
78. Shuyi Y, Feng W, Jing T, Hongzhang H, Haiyan W, Pingping M, et al. Human beta-defensin-3 (hBD-3) upregulated by LPS via epidermal growth factor receptor (EGFR) signaling pathways to enhance lymphatic invasion of oral squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2011;112:616-25.
79. Sheu JJ-C, Hua C-H, Wan L, Lin Y-J, Lai M-T, Tseng H-C, et al. Functional Genomic Analysis Identified Epidermal Growth Factor Receptor Activation as the Most Common Genetic Event in Oral Squamous Cell Carcinoma. Cancer Research. 2009;69:2568-76.
80. Luo M, Guan J-L. Focal adhesion kinase: A prominent determinant in breast cancer initiation, progression and metastasis. Cancer Letters. 2010;289:127-39.
81. Liu S, Calderwood DA, Ginsberg MH. Integrin cytoplasmic domain-binding proteins. Journal of Cell Science. 2000;113:3563-71.
82. Hunziker W, Geuze HJ. Intracellular trafficking of lysosomal membrane proteins. BioEssays. 1996;18:379-89.
83. Luo Z, Zhang L, Li Z, Li X, Li G, Yu H, et al. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC Medical Genomics. 2012;5:3.
84. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 2004;5:816-26.
85. Wang Y, Zheng X, Zhang Z, Zhou J, Zhao G, Yang J, et al. MicroRNA-149 Inhibits Proliferation and Cell Cycle Progression through the Targeting of ZBTB2 in Human Gastric Cancer. PLoS ONE. 2012;7:e41693.
86. Calalb MB, Zhang X, Polte TR, Hanks SK. Focal Adhesion Kinase Tyrosine-861 Is a Major Site of Phosphorylation by Src. Biochemical and Biophysical Research Communications. 1996;228:662-8.
87. Parsons JT, Horwitz AR, Schwartz MA. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol. 2010;11:633-43.
88. Guo R, Wang Y, Shi W-Y, Liu B, Hou S-Q, Liu L. MicroRNA miR-491-5p Targeting both TP53 and Bcl-XL Induces Cell Apoptosis in SW1990 Pancreatic Cancer Cells through Mitochondria Mediated Pathway. Molecules. 2012;17:14733-47.
89. Nakano H, Miyazawa T, Kinoshita K, Yamada Y, Yoshida T. Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-XL in colorectal cancer cells. International Journal of Cancer. 2010;127:1072-80.
90. Zhou Y, Li Y, Ye J, Jiang R, Yan H, Yang X, et al. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition. Liver International. 2013;33:1271-80.
91. Hui Z, Yiling C, Wenting Y, XuQun H, ChuanYi Z, Hui L. miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer. FEBS Letters. 2015;589:812-21.
92. Lin R-J, Lin Y-C, Yu AL. miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells. Molecular Carcinogenesis. 2010;49:719-27.
93. Molina-Pinelo S, Gutiérrez G, Pastor MD, Hergueta M, Moreno-Bueno G, García-Carbonero R, et al. MicroRNA-Dependent Regulation of Transcription in Non-Small Cell Lung Cancer. PLoS ONE. 2014;9:e90524.
94. Tu H-F, Liu C-J, Chang C-L, Wang P-W, Kao S-Y, Yang C-C, et al. The Association between Genetic Polymorphism and the Processing Efficiency of miR-149 Affects the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. PLoS ONE. 2012;7:e51606.
95. He D-X, Gu X-T, Li Y-R, Jiang L, Jin J, Ma X. Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer. FEBS Journal. 2014;281:4718-30.
96. Xu K, Liu X, Mao X, Xue L, Wang R, Chen L, et al. MicroRNA-149 Suppresses Colorectal Cancer Cell Migration and Invasion by Directly Targeting Forkhead Box Transcription Factor FOXM1. Cellular Physiology and Biochemistry. 2015;35:499-515.
97. Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Molecular Medicine. 2012;4:143-59.
98. Hall TMT. Structure and Function of Argonaute Proteins. Structure. 2005;13:1403-8.
99. Koshkin AA, Singh SK, Nielsen P, Rajwanshi VK, Kumar R, Meldgaard M, et al. LNA (Locked Nucleic Acids): Synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition. Tetrahedron. 1998;54:3607-30.
100. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotech. 2010;28:341-7.
101. Elmén J, Lindow M, Silahtaroglu A, Bak M, Christensen M, Lind-Thomsen A, et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Research. 2008;36:1153-62.
102. Rettig WJ, Old LJ. Immunogenetics of Human Cell Surface Differentiation. Annual Review of Immunology. 1989;7:481-511.
103. Hudis CA. Trastuzumab — Mechanism of Action and Use in Clinical Practice. New England Journal of Medicine. 2007;357:39-51.
104. Zhang L-L, Mu G-G, Ding Q-S, Li Y-X, Shi Y-B, Dai J-F, et al. PTEN represses colon cancer progression through inhibiting paxillin transcription via PI3K/AKT/NF-kB pathway. Journal of Biological Chemistry. 2015.
105. Deakin NO, Turner CE. Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis. Molecular Biology of the Cell. 2011;22:327-41.
106. Deakin NO, Pignatelli J, Turner CE. Diverse Roles for the Paxillin Family of Proteins in Cancer. Genes & Cancer. 2012;3:362-70.
107. Lin S-L, Miller JD, Ying S-Y. Intronic MicroRNA (miRNA). Journal of Biomedicine and Biotechnology. 2006;2006:13.
108. Geiger B, Spatz JP, Bershadsky AD. Environmental sensing through focal adhesions. Nat Rev Mol Cell Biol. 2009;10:21-33.
109. Venkatachalam R, Verwiel ETP, Kamping EJ, Hoenselaar E, Görgens H, Schackert HK, et al. Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients. International Journal of Cancer. 2011;129:1635-42.
|